Aignostics is a Berlin-based AI company that transforms multi-modal pathology data into insights for biopharmaceutical clients.

Abridge uses generative AI to convert patient-clinician conversations into structured clinical note drafts in real-time, with plans to support large-scale health system rollouts and create additional value for patients, clinicians, and health systems.

Nucleus RadioPharma is a company that aims to modernize the clinical development, manufacturing, and supply chain of radiopharmaceuticals to ensure broader patient access and improve the movement and delivery of materials to patients.

InfoBionic is a Boston-based virtual telemetry company that has developed the MoMe® ARC system, a remote, wireless monitoring and diagnosis platform for cardiac arrhythmias, which recently received FDA approval for its third-generation platform.